Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population

Environmental Health and Preventive Medicine

Volumn 17, Issue 2, 2012, Pages 147-156

  Noborisaka, Yuka ^a   Ishizaki, Masao ^a   Nakata, Minori ^a   Yamada, Yuichi ^a   Honda, Ryumon ^a   Yokoyama, Hitoshi ^a   Miyao, Masaru ^b   Tabata, Masaji ^c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Ishikawa Health Service Association   (Japan)

Author keywords

eGFR; General population; Proteinuria; Smoking; Worksite

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; KIDNEY FUNCTION; MALE; OCCUPATIONAL HEALTH; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PREVALENCE; PROTEINURIA; RISK FACTORS; SMOKING;

EID: 84862893728     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-011-0234-x     Document Type: Article

References (49)

1. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - absence of evidence or evidence of absence? Clin J Am Soc Nephrol. 2008;3:226-36.
2. Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens. 2002;11:483-8.
3. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int. 1997;51:1669-77.
4. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int. 2000;57: 2072-9.
5. Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis. 2000;35:687-94.
6. Yamada Y, Noborisaka Y, Ishizaki M, Honda R, Tsuritani I, Yamada S. Association between cigarette consumption and proteinuria in healthy Japanese men and women from an occupational population. J Occup Health. 2004;46:365-73.
7. Dales LG, Friedman GD, Siegelaub AB, Seltzer CC. Cigarette smoking and serum chemistry tests. J Chronic Dis. 1974;27: 293-307.
8. Savdie E, Grosslight GM, Adena MA. Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chronic Dis. 1984;37:617-23.
9. Noborisaka Y, Honda R, Ishizaki M, Nakata M, Yamada Y. Alcohol and cigarette consumption, renal function and blood pressure in middle-aged healthy men. J Hum Hypertens. 2007;21:966-8.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130: 461-70.
12. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
13. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100.
14. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621-30.
15. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, et al. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA. 1991;265:614-7.
16. Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis. 2002;39:376-82.
17. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes. 1995;44:916-23.
18. Warmoth L, Regalado MM, Simoni J, Harrist RB, Wesson DE. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci. 2005;330:111-9.
19. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a communitybased population: a 10-year follow-up study. Kidney Int. 2007;71: 159-66.
20. O'Seaghdha CM, Hwang SJ, Upadhyay A, Meigs JB, Fox CS. Predictors of incident albuminuria in the Framingham Offspring cohort. Am J Kidney Dis. 2010;56:852-60.
21. Klesges RC, Meyers AW, Klesges LM, La Vasque ME. Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull. 1989;106:204-30.
22. Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health. 1997;51:252-60.
23. Friedman GD, Klatsky AL, Siegelaub AB. Alcohol, tobacco, and hypertension. Hypertension. 1982;4:III143-50.
24. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111:932-40.
25. Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA. 1991;265:2226-8.
26. Pickering TG, Schwartz JE, James GD. Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol. 1995;22:226-31.
27. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens. 1992;10:495-9.
28. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33:586-90.
29. Goetz FC, Jacobs DR Jr, Chavers B, Roel J, Yelle M, Sprafka JM. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol. 1997;145:91-102.
30. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med. 2000; 133:585-91.
31. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 2000;58:1285-92.
32. Ishizaka N, Ishizaka Y, TodaEi-ichi, Shimomura H, Koike K, Seki G, et al. Association between Cigarette Smoking and Chronic Kidney Disease in Japanese Men. Hypertension Res. 2008;31:485-92.
33. Yoon HJ, Park M, Yoon H, Son KY, Cho B, Kim S. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res. 2009;32:214-9.
34. Sauriasari R, Sakano N, Wang DH, Takaki J, Takemoto K, Wang B, et al. C-reactive protein is associated with cigarette smokinginduced hyperfiltration and proteinuria in an apparently healthy population. Hypertens Res. 2010;33:1129-36.
35. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative metaanalysis. Lancet. 2010;375:2073-81.
36. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care. 1994;17:120-5.
37. Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes. 1990;39:761-7.
38. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis. 1995;25:836-44.
39. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 1992;61:94-7.
40. Ljungman S. Microalbuminuria in essential hypertension. Am J Hypertens. 1990;3:956-60.
41. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P. Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabet Med. 1994;11:666-9.
42. Mimran A, Ribstein J, DuCailar G, Halimi JM. Albuminuria in normals and essential hypertension. J Diabetes Complicat. 1994;8:150-6.
43. Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl. 2004;S22-4.
44. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care. 2000;23(Suppl 2):B35-9.
45. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519-26.
46. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751-6.
47. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-6.
48. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med. 2000;38:1107-10.
49. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004;33:189-98.